Minsu Kwon Selected Research

Therapeutics

11/2022	Coprevalence of Presbycusis and Its Effect on Outcome of Voice Therapy in Patients With Presbyphonia.
12/2021	Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
1/2021	Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer.
1/2021	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
8/2020	A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux.
2/2016	Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
10/2014	Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minsu Kwon Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 10/2014
4	Head and Neck Neoplasms (Head and Neck Cancer) 11/2016 - 10/2014
3	Squamous Cell Carcinoma of Head and Neck 12/2021 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2016
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2017 - 07/2016
1	Hepatocellular Carcinoma (Hepatoma) 04/2024
1	Coinfection 02/2024
1	COVID-19 02/2024
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2023
1	Vitamin D Deficiency 08/2023
1	Periodontitis 11/2022
1	Anemia 11/2022
1	Thrombocytopenia (Thrombopenia) 11/2022
1	Thyroid Diseases (Thyroid Disease) 11/2022
1	Presbycusis 11/2022
1	Uveal melanoma 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Laryngopharyngeal Reflux 08/2020
1	Apnea 02/2018
1	Foreign Bodies (Foreign Body) 02/2018
1	Cachexia 01/2017
1	Lymphatic Metastasis 07/2016
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2016
1	Second Primary Neoplasms (Neoplasms, Second) 05/2015

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 10/2014
3	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2021
2	Therapeutic UsesIBA 04/2024 - 10/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 02/2016 - 10/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2016 - 10/2014
1	Cancer VaccinesIBA 04/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	VaccinesIBA 04/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024
1	hydroxide ionIBA 08/2023
1	25-hydroxyvitamin DIBA 08/2023
1	Vitamin D FDA LinkGeneric 08/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	AntibodiesIBA 11/2022
1	cyclopropapyrroloindoleIBA 11/2022
1	CalreticulinIBA 12/2021
1	Programmed Cell Death 1 ReceptorIBA 12/2021
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 01/2021
1	K-115IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Terpenes (Terpenoids)IBA 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Expectorants (Mucolytics)IBA 08/2020
1	Proton Pump InhibitorsIBA 08/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017
1	olaparibIBA 11/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2016
1	Indicators and Reagents (Reagents)IBA 03/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	P-2 (P 2)IBA 05/2015
1	Metformin (Glucophage)FDA LinkGeneric 05/2015
1	CytokinesIBA 01/2015
1	Interleukin-4 (Interleukin 4)IBA 01/2015
1	Interleukin-13IBA 01/2015
1	piperlongumineIBA 10/2014

Therapy/Procedure

7	Therapeutics 11/2022 - 10/2014
5	Immunotherapy 04/2024 - 01/2021
2	Aftercare (After-Treatment) 09/2017 - 01/2017
1	Long-Term Care 02/2024
1	Ligation 11/2022
1	Oral Hygiene (Dental Hygiene) 11/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Endoscopes 02/2018
1	Surgical Instruments (Clip) 02/2018
1	Bronchoscopes 02/2018
1	Radiotherapy 07/2016